PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2012.44.3.1572012443157-165Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter StudyMee-Yon Cho, Joon Mee Kim, Jin Hee Sohn, Mi-Jung Kim, Kyoung-Mee Kim, Woo Ho Kim, Hyunki Kim, Myeong-Cherl Kook, Do Youn Park, Jae Hyuk Lee, HeeKyung Chang, Eun Sun Jung, Hee Kyung Kim, So-Young Jin, Joon Hyuk Choi, Mi Jin Gu, Sujin Kim, Mi Seon Kang, Chang Ho Cho, Moon-Il Park, Yun Kyung Kang, Youn Wha Kim, Sun Och Yoon, Han Ik Bae, Mee Joo, Woo Sung Moon, Dae Young Kang, Sei Jin Changhttp://www.e-crt.org/upload/pdf/crt-44-157.pdf, http://www.e-crt.org/upload/pdf/crt-44-157.pdf
Clinical Diabetes and Endocrinology10.1186/s40842-018-0066-3201841Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Inbal Uri, Simona Grozinsky-Glasberghttp://link.springer.com/content/pdf/10.1186/s40842-018-0066-3.pdf, http://link.springer.com/article/10.1186/s40842-018-0066-3/fulltext.html, http://link.springer.com/content/pdf/10.1186/s40842-018-0066-3.pdf
Endocrine Practice10.4158/ep13262.ra2014202167-175Systemic Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS): Cuirrent Approaches and Future OptionsJonathan R. Strosberghttps://api.elsevier.com/content/article/PII:S1530891X20437486?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1530891X20437486?httpAccept=text/plain, http://aace.metapress.com/index/201873X814443875.pdf
Indian Journal of Gastroenterology10.1007/s12664-017-0808-72017366445-451Trends in diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in India: A report of multicenter data from a web-based registryJagannath Palepu, Shailesh V. Shrikhande, Debanshu Bhaduri, Rajiv C Shah, Bhawna Sirohi, Verushka Chhabra, Puneet Dhar, Regulagedda Sastry, Sadiq Sikorahttp://link.springer.com/article/10.1007/s12664-017-0808-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12664-017-0808-7.pdf, http://link.springer.com/content/pdf/10.1007/s12664-017-0808-7.pdf
Best Practice & Research Clinical Gastroenterology10.1016/j.bpg.2013.01.0052012266689-690Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Wouter W. de Herderhttps://api.elsevier.com/content/article/PII:S1521691813000334?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1521691813000334?httpAccept=text/plain
Value in Health10.1016/j.jval.2021.04.326202124S64PCN236 A Retrospective Real-World Evidence Study of Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS) in the US Using the Optum DatabaseP. Kunz, H. Honeycutt, P. Ward, A. Dasarihttps://api.elsevier.com/content/article/PII:S109830152100543X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S109830152100543X?httpAccept=text/plain
The Oncologist10.1634/theoncologist.2011-00022011165602-613Diagnosis and Treatment of Gastroenteropancreatic Neuroendocrine Tumors: Current Data on a Prospectively Collected, Retrospectively Analyzed Clinical Multicenter InvestigationMartin B. Niederle, Bruno Niederlehttps://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2011-0002, https://onlinelibrary.wiley.com/doi/full-xml/10.1634/theoncologist.2011-0002, https://academic.oup.com/oncolo/article-pdf/16/5/602/41854101/oncolo_16_5_602.pdf, https://academic.oup.com/oncolo/article-pdf/16/5/602/41854101/oncolo_16_5_602.pdf
Gastroenterology10.1016/s0016-5085(00)84183-920001184A514Prognostic factors in patients with neuroendocrine gastroenteropancreatic (GEP) tumorsA. Sprenger, M. Wied, H.H. Mueller, A. Rickenbach, W. Mathias, R. Funk, R. Arnoldhttps://api.elsevier.com/content/article/PII:S0016508500841839?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508500841839?httpAccept=text/plain
Cancer and Metastasis Reviews10.1007/s10555-015-9598-52015344823-842Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in developmentRocio Garcia-Carbonero, , Roberto Garcia-Figueiras, Alberto Carmona-Bayonas, Isabel Sevilla, Alex Teule, Maria Quindos, Enrique Grande, Jaume Capdevila, Javier Aller, Javier Arbizu, Paula Jimenez-Fonsecahttp://link.springer.com/content/pdf/10.1007/s10555-015-9598-5.pdf, http://link.springer.com/article/10.1007/s10555-015-9598-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10555-015-9598-5
Annals of Oncology10.1016/s0923-7534(20)33717-0201223ix379-ix380Somatostatin Receptor (SSTR) Expression and Proliferative Index (KI 67) in 100 Patients (PTS) with Gastroenteropancreatic Neuroendocrine Tumors (Gep-Nets). Clinical-Pathological CorrelationJ.M. Oconnor, S. Belli, V. Pesce, C. Bestani, G. Mendez, E. Dominichini, A. Cabanne, G. Lopez, F. Marmissolle, E. Rocahttps://api.elsevier.com/content/article/PII:S0923753420337170?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420337170?httpAccept=text/plain